Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Boehringer Ingelheim Limited
Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 19/07/2011
PIL Micardis 20mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to manufacturer contact details
  • Change to MA holder contact details
Updated on 06/06/2011 and displayed until 19/07/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 23/12/2009 and displayed until 06/06/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
Updated on 02/09/2009 and displayed until 23/12/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 28/08/2009 and displayed until 02/09/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 26/08/2009 and displayed until 28/08/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 06/08/2009 and displayed until 26/08/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/07/2009 and displayed until 06/08/2009
Reasons for adding or updating:
  • Change of contra-indications
  • Change to information about pregnancy or lactation
Updated on 04/06/2009 and displayed until 29/07/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 23/09/2008 and displayed until 04/06/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 28/11/2007 and displayed until 23/09/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/05/2006 and displayed until 28/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 23/12/2002 and displayed until 09/05/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  telmisartan